ID

37052

Descripción

Effect of Andosan in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01815411

Link

https://clinicaltrials.gov/show/NCT01815411

Palabras clave

Versiones (1)
  1. 1/7/19 1/7/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

1 de julio de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Rheumatoid Arthritis NCT01815411

Inglés

Eligibility Rheumatoid Arthritis NCT01815411

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age>18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
able and willing to give written informed consent, and to comply with the requirements of the study protocol.
Descripción

Informed Consent | Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0525058
fulfilling the acr 1987 revised diagnostic criteria for the diagnosis rheumatoid arthritis.
Descripción

Rheumatoid Arthritis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003873
moderate disease activity based on the clinical evaluation including das28-esr (das28 3.2-5.1) [11, 12].
Descripción

Moderate disease activity DAS28

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2368567
UMLS CUI [1,2]
C4481729
stable medication by disease modifying drugs (dmards) and systemic glucocorticosteroids for 3 months prior to the inclusion.
Descripción

DMARDs Stable | Systemic Glucocorticoids Stable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0242708
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C3540777
UMLS CUI [2,2]
C0205360
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
lack of cooperativity.
Descripción

Cooperative Behavior Lacking

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009964
UMLS CUI [1,2]
C0332268
clinically significant chronic infection, including positive serology for hepatitis b or c, history of positive hiv status.
Descripción

Chronic infectious disease | Hepatitis B Seropositive | Hepatitis C Seropositive | HIV Seropositivity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151317
UMLS CUI [2,1]
C0019163
UMLS CUI [2,2]
C0521143
UMLS CUI [3,1]
C0019196
UMLS CUI [3,2]
C0521143
UMLS CUI [4]
C0019699
acute significant infection during the last 3 weeks before the inclusion. surgery during the last 4 weeks before the inclusion, and during the study period.
Descripción

Communicable Disease | Operative Surgical Procedures

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0543467
clinically significant malignancy .
Descripción

Malignant Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
drug addiction
Descripción

Drug Dependence

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1510472
any inflammatory disease of permanence not related to ra.
Descripción

Inflammatory disorder Permanent | Relationship Absent Rheumatoid Arthritis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1290884
UMLS CUI [1,2]
C0205355
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0003873
use of prednisolone >7,5 mg daily for 1 month prior to the inclusion.
Descripción

Prednisolone U/day

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0032950
UMLS CUI [1,2]
C0456683
use of biologic treatment including antibodies to cytokines and their receptors for 6 weeks prior to the inclusion.
Descripción

Biological treatment | Antibodies Cytokine | Antibodies Cytokine Receptors

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1531518
UMLS CUI [2,1]
C3495458
UMLS CUI [2,2]
C0079189
UMLS CUI [3,1]
C3495458
UMLS CUI [3,2]
C0206552
use of intramuscular, intra-articular or intravenous injections of corticosteroids during or within 4 weeks prior to inclusion in the trial.
Descripción

Adrenal Cortex Hormones Intramuscular injection | Intraarticular injection of corticosteroids | Adrenal Cortex Hormones Intravenous Injection

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0021492
UMLS CUI [2]
C2064783
UMLS CUI [3,1]
C0001617
UMLS CUI [3,2]
C0021494
vaccination during the trial.
Descripción

Vaccination

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0042196
pregnancy or breast-feeding.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Rheumatoid Arthritis NCT01815411

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age>18 years
boolean
C0001779 (UMLS CUI [1])
Informed Consent | Protocol Compliance
Item
able and willing to give written informed consent, and to comply with the requirements of the study protocol.
boolean
C0021430 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
Rheumatoid Arthritis
Item
fulfilling the acr 1987 revised diagnostic criteria for the diagnosis rheumatoid arthritis.
boolean
C0003873 (UMLS CUI [1])
Moderate disease activity DAS28
Item
moderate disease activity based on the clinical evaluation including das28-esr (das28 3.2-5.1) [11, 12].
boolean
C2368567 (UMLS CUI [1,1])
C4481729 (UMLS CUI [1,2])
DMARDs Stable | Systemic Glucocorticoids Stable
Item
stable medication by disease modifying drugs (dmards) and systemic glucocorticosteroids for 3 months prior to the inclusion.
boolean
C0242708 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C3540777 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Cooperative Behavior Lacking
Item
lack of cooperativity.
boolean
C0009964 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
Chronic infectious disease | Hepatitis B Seropositive | Hepatitis C Seropositive | HIV Seropositivity
Item
clinically significant chronic infection, including positive serology for hepatitis b or c, history of positive hiv status.
boolean
C0151317 (UMLS CUI [1])
C0019163 (UMLS CUI [2,1])
C0521143 (UMLS CUI [2,2])
C0019196 (UMLS CUI [3,1])
C0521143 (UMLS CUI [3,2])
C0019699 (UMLS CUI [4])
Communicable Disease | Operative Surgical Procedures
Item
acute significant infection during the last 3 weeks before the inclusion. surgery during the last 4 weeks before the inclusion, and during the study period.
boolean
C0009450 (UMLS CUI [1])
C0543467 (UMLS CUI [2])
Malignant Neoplasms
Item
clinically significant malignancy .
boolean
C0006826 (UMLS CUI [1])
Drug Dependence
Item
drug addiction
boolean
C1510472 (UMLS CUI [1])
Inflammatory disorder Permanent | Relationship Absent Rheumatoid Arthritis
Item
any inflammatory disease of permanence not related to ra.
boolean
C1290884 (UMLS CUI [1,1])
C0205355 (UMLS CUI [1,2])
C0439849 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0003873 (UMLS CUI [2,3])
Prednisolone U/day
Item
use of prednisolone >7,5 mg daily for 1 month prior to the inclusion.
boolean
C0032950 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
Biological treatment | Antibodies Cytokine | Antibodies Cytokine Receptors
Item
use of biologic treatment including antibodies to cytokines and their receptors for 6 weeks prior to the inclusion.
boolean
C1531518 (UMLS CUI [1])
C3495458 (UMLS CUI [2,1])
C0079189 (UMLS CUI [2,2])
C3495458 (UMLS CUI [3,1])
C0206552 (UMLS CUI [3,2])
Adrenal Cortex Hormones Intramuscular injection | Intraarticular injection of corticosteroids | Adrenal Cortex Hormones Intravenous Injection
Item
use of intramuscular, intra-articular or intravenous injections of corticosteroids during or within 4 weeks prior to inclusion in the trial.
boolean
C0001617 (UMLS CUI [1,1])
C0021492 (UMLS CUI [1,2])
C2064783 (UMLS CUI [2])
C0001617 (UMLS CUI [3,1])
C0021494 (UMLS CUI [3,2])
Vaccination
Item
vaccination during the trial.
boolean
C0042196 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or breast-feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial